Updated Jul 16, 2026
Elmelech Idan has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Elmelech Idan appears in SEC filing context related to BridgeBio Oncology Therapeutics, Inc. as of 2026-05-12. The provided context confirms an association with BridgeBio Oncology, but the exact title, role, and responsibilities are not specified in the given information. There is no independent biographical detail available in the prompt beyond the SEC context.
| Role | Insider |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | BBOT | BridgeBio Oncology Therapeutics, Inc. | F — Tax withholding / forfeiture | 343 | $7.80 | $3K |
Elmelech Idan appears in SEC filing context related to BridgeBio Oncology Therapeutics, Inc. as of 2026-05-12. The provided context confirms an association with BridgeBio Oncology, but the exact title, role, and responsibilities are not specified in the given information. There is no independent biographical detail available in the prompt beyond the SEC context.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Elmelech Idan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.